Molecular docking studies on α-amylase inhibitory peptides from milk of different farm animals

• Published in: Journal of dairy science 2024-05, Vol.107 (5), p.2633-2652
• Main Authors: Mudgil, Priti, Al Dhaheri, Mouza Khamis Obaid, Alsubousi, Maitha Saif Mohammed, Khan, Hina, Redha, Ali Ali, Yap, Pei-Gee, Gan, Chee-Yuen, Maqsood, Sajid
• Format: Article
• Language: English
• Subjects: antidiabetic bioactive peptides; milk fermentation; molecular docking; probiotics; α-amylase inhibition
• ISSN: 0022-0302; 1525-3198
• DOI: 10.3168/jds.2023-24118

Milk-derived peptides have emerged as a popular mean to manage various lifestyle disorders such as diabetes. Fermentation is being explored as one of the faster and efficient way of producing peptides with antidiabetic potential. Therefore, in this study, an attempt was made to comparatively investigate the pancreatic α-amylase (PAA) inhibitory properties of peptides derived from milk of different farm animals through probiotic fermentation. Peptide's identification was carried out using liquid chromatography-quadrupole time-of-flight mass spectrometry and inhibition mechanisms were characterized by molecular docking. Results obtained showed a PAA-IC50 value (the amount of protein equivalent needed to inhibit 50% of enzymes) between 2.39 and 36.1 µg protein equivalent for different fermented samples. Overall, Pediococcus pentosaceus MF000957-derived fermented milk from all animals indicated higher PAA inhibition than other probiotic derived fermented milk (PAA-IC50 values of 6.01, 3.53, 15.6, and 10.8 µg protein equivalent for bovine, camel, goat, and sheep fermented milk). Further, molecular docking analysis indicated that camel milk-derived peptide IMEQQQTEDEQQDK and goat milk-derived peptide DQHQKAMKPWTQPK were the most potent PAA inhibitory peptides. Overall, the study concluded that fermentation derived peptides may prove useful in for managing diabetes via inhibition of carbohydrate digesting enzyme PAA. [Display omitted]